Oxford/AstraZeneca Covid-19 vaccine: a vital opportunity for emerging markets
Oxford University/AstraZeneca Covid-19 vaccine, based on viral vector technology and now approved by UK authorities, will be vital for...
Oxford/AstraZeneca Covid-19 vaccine: a vital opportunity for emerging markets
The end of Swedish Covid-19 exception ?
Remote monitoring for cancer patients with Covid-19: lessons learned
Taking necessary time to approve Covid19 vaccines
Hospital patient volumes re-start increasing, for now
Integrating remote patient monitoring in clinical workflow
Diabetic Foot Amputations skyrocket due to Covid
Delivering emergency care outside emergency department ?
Surgeons expect elective procedures to restart in September
Lessons learned for post-Covid 19 cancer care in Europe
80% elective surgeries were postponed, return to normal might take a year
Covid-19 screening will be critical, but test accuracy is questioned
April 8th: deaths rebounds in EU5, US. loosening confinement sounds premature
Nordics show extremely diverse COVID-19 situation.
High level of Covid-19 testing proves beneficial
COVID-19 daily deaths in EU5-US slows down for IT, flattens for FR, DE
Germany Covid-19 casualty rate is among world's lowest, thanks to tests and critical care
COVID-19 outbreak exposes limits of U.S. healthcare
Social distancing is critical to avoid saturation of healthcare systems
3 scenarios for COVID-19 outbreak economic impact